Johnson & Johnson(JNJ)
Johnson & Johnson_2 Recent FDA Wins And Earnings Beat Warrant 'Buy' Rating (Buy)
JNJ (Buy)
JNJ Q3 Earnings Surprise, Icotrokinra Shines Again (Buy)
Johnson & Johnson rises after reporting Q3 results, raises FY guidance
(Earnings Call Insights) Johnson & Johnson outlines orthopaedics spin-off and targets 5.7% reported sales growth for 2025 amid accelerating MedTech and Innovative Medicine momentum
Johnson & Johnson To Acquire Protagonist It'd Be A Good Deal To Make (Buy)
Johnson and Johnson - JNJ (Buy)
Johnson& Johnson All-Time Highs In Sigh…Raised Guidance And A Technical Breakout (Buy)
Johnson & Johnson Stock Could Be Waking Up (Buy)
